Filing Details
- Accession Number:
- 0001641172-25-015241
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-06-16 16:05:28
- Reporting Period:
- 2025-06-13
- Filing Date:
- 2025-06-16
- Accepted Time:
- 2025-06-16 16:05:28
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1534708 | Beeline Holdings Inc. | BLNE | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1264473 | Jr Reyland Nicholas Liuzza | 188 Valley Street, Suite 225 Providence, RI 02909 | Chief Executive Officer | Yes | Yes | Yes | No |
Transaction Summary
Purchased: | 113,500 shares | Avg. Price: $0.66 | Total Value: $74,913.73 |
Number of Shares After Transactions: | 1,881,548 shares |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2025-06-13 | 10 | $0.66 | 1,768,058 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2025-06-13 | 2,906 | $0.66 | 1,770,964 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2025-06-13 | 217 | $0.66 | 1,771,181 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2025-06-13 | 108,467 | $0.66 | 1,879,648 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2025-06-13 | 400 | $0.66 | 1,880,048 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2025-06-13 | 1,500 | $0.66 | 1,881,548 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series G Convertible Preferred Stock | Acquisiton | 2025-06-13 | 296,078 | $0.00 | 90,149 | $1.67 |
Common Stock | Warrants to Purchase Common Stock | Acquisiton | 2025-06-13 | 145,797 | $0.00 | 145,797 | $0.66 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
7,937,567 | No | 4 | A | Direct | ||
3,908,677 | No | 4 | A | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 223,716 | Indirect | Nicholas R. Liuzza Jr. Trust - 2020 |
Footnotes
- The reporting person is trustee of the trust, and members of the reporting person's immediate family are beneficiaries of the trust.
- Represents Series G Convertible Preferred Stock ("Series G") purchased by the reporting person pursuant to a Securities Purchase Agreement with the issuer. The Series G are convertible into common stock at a conversion price of $1.67 per share.
- The preferred stock is perpetual and therefore has no expiration date.
- The reporting person paid a purchase price of $151,000 for the Series G and accompanying warrants. The reporting person had previously purchased $3,897,159 of Series G and accompanying warrants in transactions prior to June 13, 2025 as previously reported on prior Form 4s, for a total investment in the Series G and accompanying warrants of $4,048,159. Common stock amounts give effect to price protection adjustment provisions, which may be subject to further adjustments based on lower priced sales of common stock or common stock equivalents by the Company or if the Company obtains waivers to such adjustment provisions from the holders of these securities. Conversions of Series G and exercise of warrants are subject to shareholder approval as and to the extent required by the rules of The Nasdaq Capital Market.
- Represents common stock purchase warrants having a five-year term, which were purchased pursuant to the Securities Purchase Agreement referred to in footnote (2).